The Biden administration has unveiled plans for a public-private partnership to strengthen the resilience of a US pharmaceutical supply chain that was sorely tested by COVID-19.
Public-Private Consortium To Strengthen Essential Medicines Supply Under White House Initiative
President Biden’s 100-day plan relies on Defense Production Act authorities to increase resilience of critical domestic pharmaceutical supplies.
